Yale School of Medicine Receives $10 Million Donation
On November 17, 2026, Yale School of Medicine made headlines by announcing a generous $10 million donation from Anastasia and Igor Bukhman, facilitated through the Bukhman Foundation. This significant funding is earmarked for a collaborative five-year research initiative focused on reversing type 1 diabetes with the ultimate goal of curing the disease.
Dr. Nancy J. Brown, the Jean and David W. Wallace Dean of Yale School of Medicine, expressed heartfelt gratitude for the Bukhmans' trust and contribution, stating, "This charitable donation will support our researchers in developing targeted therapies that will change the course of type 1 diabetes and ultimately prevent its onset." This research is particularly personal for the Bukhman family, as type 1 diabetes has directly affected them, including the diagnosis of Anastasia's daughter at the age of three. Anastasia remarked, "This disease has a long-term impact on our family and profoundly affects the work we do today."
The research led by Dr. Kevan Herold, a prominent immunobiologist and professor of medicine (endocrinology), will concentrate on preventing the immune system from attacking beta cells, which are vital for insulin production. Furthermore, the research aims to create personalized treatment options based on each patient's genetic and immune characteristics. Dr. Herold noted, "This donation will fund multiple studies, all focused on blocking the immune-mediated onset of type 1 diabetes and restoring lost insulin-producing beta cells. Our goal is clear: to prevent or reverse the disease."
Besides Herold, the initiative will bolster the research of several distinguished scientists, including:
- - Dr. Esen Sefik, Assistant Professor of Immunobiology, who will enhance disease modeling and reveal variations in immune cell characteristics among different patients.
- - Dr. Richard Flavell, Sterling Professor of Immunobiology, who will leverage expertise in mouse models to investigate the immune system.
- - Dr. Nikhil Joshi, Professor of Immunobiology and Co-Director of Cancer Immunology at the Yale Cancer Center, who will explore immune cell behavior and tolerance issues in type 1 diabetes through insights from cancer immunology.
- - Dr. Richard Kibbey, who focuses on beta cell biology and strategies for enhancing the survival and function of alternative insulin-producing cells.
- - Dr. John Tsang, Professor of Immunobiology and Biomedical Engineering, who will utilize computational modeling to analyze complex immune data, which is crucial for identifying individual patient characteristics.
Yale School of Medicine is committed to cultivating leaders in the fields of medicine and science, emphasizing curiosity and critical inquiry. The institution is recognized globally for its excellence in biomedical research, clinical care, and medical education. With more than 1,700 physicians, Yale provides compassionate medical services to patients worldwide, and its educational framework promotes critical thinking and independent research, nurturing future leaders in the medical academia.